VBL Therapeutics (NASDAQ: VBLT) today announced the pricing of its previously announced underwritten public offering of 2,500,000 ordinary shares ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE